Facilitation of drug evaluation in children by population methods and modelling

M Tod, V Jullien, G Pons - Clinical pharmacokinetics, 2008 - Springer
The pharmacokinetics and pharmacodynamics of drugs are different in adult and paediatric
populations, the latter being particularly heterogeneous. These differences in …

Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates

M Wilbaux, A Fuchs, J Samardzic… - The Journal of …, 2016 - Wiley Online Library
Sepsis remains a major cause of mortality and morbidity in neonates, and, as a
consequence, antibiotics are the most frequently prescribed drugs in this vulnerable patient …

[图书][B] Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, -Three Volume Set

ML Grayson, S Cosgrove, S Crowe, W Hope… - 2017 - books.google.com
Kucers' The Use of Antibiotics is the definitive, internationally-authored reference, providing
everything that the infectious diseases specialist and prescriber needs to know about …

Developmental pharmacokinetics of antibiotics used in neonatal ICU: focus on preterm infants

OI Butranova, EA Ushkalova, SK Zyryanov… - Biomedicines, 2023 - mdpi.com
Neonatal Infections are among the most common reasons for admission to the intensive
care unit. Neonatal sepsis (NS) significantly contributes to mortality rates. Empiric antibiotic …

Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling

PJ De Sutter, P Rossignol, L Breëns, E Gasthuys… - Pharmaceutics, 2023 - mdpi.com
The volume of distribution at steady state (Vss) in neonates is still often estimated through
isometric scaling from adult values, disregarding developmental changes beyond body …

Population pharmacokinetic analysis during the first 2 years of life: an overview

A Marsot, A Boulamery, B Bruguerolle… - Clinical pharmacokinetics, 2012 - Springer
Three decades after its introduction, pharmacokinetic population approaches have become
a reference method for drug modelling, particularly in paediatrics. The main practical …

Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus Intermittent Administration

E Leegwater, L Wewerinke, AM de Grauw… - Clinical …, 2023 - Springer
Abstract Background and Objective In neonates, β-Lactam antibiotics are almost exclusively
administered by intermittent infusion. However, continuous or prolonged infusion may be …

[HTML][HTML] Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology

CIS Barker, E Germovsek, RL Hoare, JM Lestner… - Advanced drug delivery …, 2014 - Elsevier
Pharmacokinetic/pharmacodynamic (PKPD) modelling is used to describe and quantify
dose–concentration–effect relationships. Within paediatric studies in infectious diseases and …

Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates

RFW De Cock, A Smits, K Allegaert… - Journal of …, 2014 - academic.oup.com
Objectives Cefazolin is frequently administered for antimicrobial prophylaxis and treatment
of infections. In neonates, pharmacokinetic observations are limited and dosing regimens …

Pharmacokinetic studies in infants using minimal-risk study designs

J Autmizguine, P Brian Smith… - Current clinical …, 2014 - ingentaconnect.com
Infants are therapeutic orphans. Many drugs used in infants are used “off-label”, increasing
the risk of drug toxicity and suboptimal efficacy in this vulnerable population. This knowledge …